T Venkatesan1, Y Zadvornova1, H Raff2, C J Hillard3. 1. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, USA. 2. Departments of Medicine, Surgery, and Physiology, Medical College of Wisconsin, Endocrine Research Laboratory, Aurora St. Luke's Medical Center - Aurora Research Institute, Milwaukee, WI, USA. 3. Neuroscience Research Center, Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
Abstract
BACKGROUND: The endocannabinoid system and the hypothalamic-pituitary-adrenal axis are important neuromodulators of nausea and vomiting. This led us to hypothesize that patients with cyclic vomiting syndrome (CVS) have lower serum endocannabinoids (eCBs) and higher salivary cortisol and alpha amylase. METHODS: Serum eCBs and related lipids, N-oleoylethanolamine (OEA) and N-palmitoylethanolamide (PEA), and salivary cortisol, and alpha amylase (index of sympathetic nervous system activity) were measured in 22 CVS patients (age 40 ± 11, female = 17) in the well and sick phases and 12 matched controls (age 37 ± 12, female = 10). KEY RESULTS: Contrary to our hypothesis, serum concentrations of the eCBs were not different among the study groups. However, serum concentrations of OEA and PEA were significantly higher during the sick than well phase in CVS patients (p = 0.001 and p = 0.04). There were positive correlations between serum PEA and nausea scores in the sick phase (Pearson's rho = 0.48, p = 0.036) and between serum OEA and poor sleep quality in patients (Pearson's rho = 0.7, p = 0.0005). Salivary cortisol and alpha amylase were not different between patients and controls, but subgroup analysis revealed that both were significantly higher in marijuana users compared to non-users during the sick phase (p = 0.04 and 0.03, respectively). CONCLUSIONS & INFERENCES: These data demonstrate that eCB-related lipids, OEA and PEA, are mobilized in the sick phase of CVS and are positively correlated with several of the symptoms of a CVS episode. These data also suggest the hypothesis that chronic marijuana use results in enhanced stress responses during CVS.
BACKGROUND: The endocannabinoid system and the hypothalamic-pituitary-adrenal axis are important neuromodulators of nausea and vomiting. This led us to hypothesize that patients with cyclic vomiting syndrome (CVS) have lower serum endocannabinoids (eCBs) and higher salivary cortisol and alpha amylase. METHODS: Serum eCBs and related lipids, N-oleoylethanolamine (OEA) and N-palmitoylethanolamide (PEA), and salivary cortisol, and alpha amylase (index of sympathetic nervous system activity) were measured in 22 CVS patients (age 40 ± 11, female = 17) in the well and sick phases and 12 matched controls (age 37 ± 12, female = 10). KEY RESULTS: Contrary to our hypothesis, serum concentrations of the eCBs were not different among the study groups. However, serum concentrations of OEA and PEA were significantly higher during the sick than well phase in CVS patients (p = 0.001 and p = 0.04). There were positive correlations between serum PEA and nausea scores in the sick phase (Pearson's rho = 0.48, p = 0.036) and between serum OEA and poor sleep quality in patients (Pearson's rho = 0.7, p = 0.0005). Salivary cortisol and alpha amylase were not different between patients and controls, but subgroup analysis revealed that both were significantly higher in marijuana users compared to non-users during the sick phase (p = 0.04 and 0.03, respectively). CONCLUSIONS & INFERENCES: These data demonstrate that eCB-related lipids, OEA and PEA, are mobilized in the sick phase of CVS and are positively correlated with several of the symptoms of a CVS episode. These data also suggest the hypothesis that chronic marijuana use results in enhanced stress responses during CVS.
Authors: T Venkatesan; T Prieto; A Barboi; B Li; A Schroeder; W Hogan; A Ananthakrishnan; S Jaradeh Journal: Neurogastroenterol Motil Date: 2010-12 Impact factor: 3.598
Authors: F C Machado Rocha; S C Stéfano; R De Cássia Haiek; L M Q Rosa Oliveira; D X Da Silveira Journal: Eur J Cancer Care (Engl) Date: 2008-07-09 Impact factor: 2.520
Authors: T L Abell; K A Adams; R G Boles; A Bousvaros; S K F Chong; D R Fleisher; W L Hasler; P E Hyman; R M Issenman; B U K Li; S L Linder; E A Mayer; R W McCallum; K Olden; H P Parkman; C D Rudolph; Y Taché; S Tarbell; N Vakil Journal: Neurogastroenterol Motil Date: 2008-04 Impact factor: 3.598
Authors: Dagmar Koethe; Andrea Giuffrida; Daniela Schreiber; Martin Hellmich; Frauke Schultze-Lutter; Stefan Ruhrmann; Joachim Klosterkötter; Daniele Piomelli; F Markus Leweke Journal: Br J Psychiatry Date: 2009-04 Impact factor: 9.319
Authors: Eric Murillo-Rodríguez; Marcela Palomero-Rivero; Diana Millán-Aldaco; Oscar Arias-Carrión; René Drucker-Colín Journal: PLoS One Date: 2011-07-14 Impact factor: 3.240
Authors: Andrzej Wasilewski; Urszula Lewandowska; Paula Mosinska; Cezary Watala; Martin Storr; Jakub Fichna; Thangam Venkatesan Journal: Am J Gastroenterol Date: 2017-03-28 Impact factor: 10.864
Authors: Marieka V DeVuono; Olivia La Caprara; Gavin N Petrie; Cheryl L Limebeer; Erin M Rock; Matthew N Hill; Linda A Parker Journal: Cannabis Cannabinoid Res Date: 2020-12-21
Authors: Marieka V DeVuono; Kelly M Hrelja; Gavin N Petrie; Cheryl L Limebeer; Erin M Rock; Matthew N Hill; Linda A Parker Journal: Cannabis Cannabinoid Res Date: 2020-12-15